ClinicalTrials.Veeva

Menu

Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3 (SMINC-3)

Karolinska Institute logo

Karolinska Institute

Status

Enrolling

Conditions

Myocardial Infarction with Nonobstructive Coronary Arteries

Treatments

Diagnostic Test: Cardiac magnetic resonance imaging to study coronary microvascular dysfunction

Study type

Interventional

Funder types

Other

Identifiers

NCT05426408
SMINC-3

Details and patient eligibility

About

The present pilot study will investigate the prevalence of CMD in an unselected cohort of patients with the working diagnosis MINOCA and to study if the diagnostic yield can be improved by adding adenosine to the CMR investigation. Patient will be their own controls.

Enrollment

85 estimated patients

Sex

All

Ages

35 to 79 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50%
  • age 35-80 years
  • reading and writing proficiency in Swedish

Exclusion criteria

  • Claustrofobia
  • Arrythmia and/or pacemaker (atrial fibrillation and AV-block I- III)
  • Asthma or severe chronic obstructive lung disease
  • eGFR < 30 ml/min
  • spontaneous coronary artery dissection
  • acute pulmonary embolism
  • acute myocardial infarction type 2
  • cardiomyopathy other than takotsubo syndrome
  • a previous myocardial infarction due to CAD

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

85 participants in 1 patient group

Patients with MINOCA undergoing CMR
Other group
Description:
Patients will be their own controls
Treatment:
Diagnostic Test: Cardiac magnetic resonance imaging to study coronary microvascular dysfunction

Trial contacts and locations

1

Loading...

Central trial contact

Per Tornvall, MD; Peder Sörensson, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems